Telomeres Might Predict Lung Cancer Recurrence
Telomeres are sections of DNA that tell an interesting story about lifespan. Shorter telomeres usually suggest a shorter life -- but new research by a Wilmot lung cancer expert shows that longer telomeres might be a promising biomarker for a recurrence of early stage lung cancer.
A new medical imaging technology – dubbed multispectral photoacoustic imaging – has demonstrated that it can successfully identify healthy vs. cancerous prostate tissue and could represent a less invasive and more accurate way to screen for the disease.
7/18/2013 | 0 comments
When the Rochester Melanoma Action Group was looking for a place to invest its first $25,000 seed grant, it found Glynis Scott, M.D., an accomplished skin pathologist at the University of Rochester Medical Center and Wilmot Cancer Center, who’s been investigating the basic biology of melanoma for several years.
6/13/2013 | 0 comments
Scientists believe they’ve figured out a way to suppress the growth of tumors by keeping DNA tightly packaged -- essentially burying some of the genes responsible for cancer. It’s a little like keeping the lid on the jack-in-the-box, said Willis Li, Ph.D., a professor of Medicine at UC San Diego, who did the work while in the Department of Biomedical Genetics at URMC.
6/6/2013 | 0 comments
Esophageal cancer is associated with GERD (gastrointestinal reflux disease), obesity, alcohol, and tobacco abuse. But the long march toward malignancy starts 10 to 20 years earlier when the cells, genes, and signaling pathways in the foregut begin a nefarious cooperative dance.
6/5/2013 | 0 comments
A team of researchers has successfully pinpointed the unique genetic characteristics of gliomas – a common and potentially deadly form of brain cancer. The findings present scientists with a rich new set of targets for new therapies.
5/31/2013 | 0 comments